Back

Corrigendum to: P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications

European Heart Journal

8 April 2022
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes Public Health and Health Economics PREVENTIVE CARDIOLOGY Risk Factors and Prevention Pharmacology and Pharmacotherapy
You may be interested in
thumbnail
Congress Presentation
Comparative safety and effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndrome. An on treatment analysis from the multicenter CREA ARIAM Andalucia registry
19 March 2022
thumbnail
Congress Presentation
Patients adherence to the therapy after acute coronary syndrome undergoing PCI and its impact on hospitalizations and all- cause mortality during one year of follow up
29 June 2021
thumbnail
Congress Presentation
Choice of P2Y12 inhibitor and clinical outcomes in the AUGUSTUS study: support for an individualised approach
30 August 2020
thumbnail
Congress Presentation
Antiplatelet therapy prescription patterns for acute coronary syndrome: a decade analysed
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources